Fund shareholders of ACADIA Pharmaceuticals Inc
ISIN US0042251084 · United States · LEI 529900O3044NO0PEA039
- Fund shareholders
- 329
- Of which ETFs
- 95 234 other funds
- Value held
- 1.3B $ 176.9K € · 12M SEK
- Share of capital
- 32.6 % of 172.3M shares on Jul 28, 2026
329 funds hold this company. This table lists the 328 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| SA Franklin Tactical Opportunities Portfolio SUNAMERICA SERIES TRUST | 757 | 17K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 740 | 16.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Hypatia Women CEO ETF Two Roads Shared Trust | 736 | 16.5K $ | 0.19 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 679 | 15.2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SMALL-CAP GROWTH PROFUND ProFunds | 678 | 15.2K $ | 0.33 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Momentum Tilt ETF SPDR SERIES TRUST | 619 | 13.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 618 | 13.8K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 528 | 11.9K $ | 0.16 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 421 | 9.4K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 395 | 9.7K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 332 | 7.5K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis Responsible U.S. Equity ETF American Century ETF Trust | 321 | 7.9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 318 | 7.1K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Equity ETF American Century ETF Trust | 296 | 7.3K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 284 | 6.3K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 230 | 5.2K $ | 0.07 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Enhanced U.S. All-Cap Equity ETF Fidelity Covington Trust | 200 | 4.5K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 170 | 3.8K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 167 | 3.7K $ | 0.12 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 163 | 4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 128 | 3.1K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 117 | 2.9K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 80 | 2K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Victory Cornerstone Aggressive Fund Victory Portfolios III | 79 | 1.9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 39 | 957.8 $ | 0.09 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 33 | 734.6 $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TOP CLASS HEALTHCARE, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 91K € | 0.68 % | as of Dec 31, 2025 ↗ | ||
| CINVEST,FI CINVEST/ AZERO GLOBAL GESALCALA, S.A., S.G.I.I.C. | 86K € | 6.13 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| CINVEST,FI CINVEST/ AZERO GLOBAL GESALCALA, S.A., S.G.I.I.C. | 6.13 % | as of Dec 31, 2025 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 3.61 % | as of Apr 30, 2026 ↗ |
| ALGER WEATHERBIE SPECIALIZED GROWTH FUND ALGER FUNDS | 3.35 % | as of Apr 30, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 2.95 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 2.68 % | as of Feb 28, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 2.59 % | as of Apr 30, 2026 ↗ |
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 2.44 % | as of Feb 28, 2026 ↗ |
| Invesco S&P SmallCap Health Care ETF Invesco Exchange-Traded Fund Trust II | 1.83 % | as of Feb 28, 2026 ↗ |
| Allspring SMID Core ETF ALLSPRING EXCHANGE-TRADED FUNDS TRUST | 1.81 % | as of Mar 31, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 1.32 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 325 | +2 | 56,117,956 | +3.4 % |
| 2026Q1 | 323 | -10 | 54,263,444 | +1.5 % |
| 2025Q4 | 333 | +20 | 53,475,256 | +1.3 % |
| 2025Q3 | 313 | -1 | 52,799,008 | -3.8 % |
| 2025Q2 | 314 | +57 | 54,893,778 | +40.1 % |
| 2025Q1 | 257 | +3 | 39,177,440 | -2.5 % |
| 2024Q4 | 254 | -5 | 40,170,699 | +3.9 % |
| 2024Q3 | 259 | -31 | 38,671,065 | -6.8 % |
| 2024Q2 | 290 | +21 | 41,505,083 | -4.0 % |
| 2024Q1 | 269 | +2 | 43,229,803 | +3.0 % |
| 2023Q4 | 267 | 41,984,818 |
Institutional managers
332 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | 42,896,690 | 954.9M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 21,550,921 | 479.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 8,332,771 | 185.5M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 7,144,524 | 159M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,464,689 | 77.1M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 3,343,868 | 74.4M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 3,155,160 | 70.2M $ | as of Mar 31, 2026 |
| Palo Alto Investors LP | 2,872,695 | 63.9M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 2,577,916 | 57.4M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 2,471,199 | 55M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 2,026,044 | 44.7M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 1,724,196 | 38.4M $ | as of Mar 31, 2026 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,569,491 | 34.9M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,557,804 | 34.7M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,553,770 | 34.6M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 1,438,198 | 32M $ | as of Mar 31, 2026 |
| Artisan Partners Limited Partnership | 1,331,813 | 29.6M $ | as of Mar 31, 2026 |
| FRED ALGER MANAGEMENT, LLC | 1,277,151 | 28.4M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 1,272,611 | 28.3M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,173,560 | 26.1M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,093,151 | 24.3M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 1,036,987 | 23.1M $ | as of Mar 31, 2026 |
| Rockefeller Capital Management L.P. | 1,027,357 | 22.9M $ | as of Mar 31, 2026 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1,019,824 | 22.7M $ | as of Mar 31, 2026 |
| Allspring Global Investments Holdings, LLC | 954,855 | 21.3M $ | as of Mar 31, 2026 |
Declared shareholders of ACADIA Pharmaceuticals Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Portfolio Management | 5.15 % | 8,781,007 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of ACADIA Pharmaceuticals Inc". https://titelia.com/en/stocks/acadia-pharmaceuticals-inc-US0042251084